State NJ
Clinical Trials in New Jersey
Recruiting clinical trials with at least one study location in New Jersey. Data updated daily from ClinicalTrials.gov.
Top Conditions in New Jersey
NCT06630806 Phase 1
Recruiting
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneou...
Condition
Plasma Cell Myeloma Refractory
Enrollment
87 pts
Location
United States, Australia, Canada
Sponsor
Sanofi
NCT02227251 Phase 2
Recruiting
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Ly...
Condition
Diffuse Large B-cell Lymphoma
Enrollment
244 pts
Location
United States, Australia, Austria
Sponsor
Karyopharm Therapeutics Inc
NCT05948566 Phase 2
Recruiting
Strategy for Improving Stroke Treatment Response
Condition
Ischemic Stroke
Enrollment
300 pts
Location
United States
Sponsor
Translational Sciences, Inc.
NCT07399977 N/A
Recruiting
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboemboli...
Condition
Venous Thromboembolism
Enrollment
259 pts
Location
United States, Australia
Sponsor
Memorial Sloan Kettering Cance
NCT05238922 Phase 1
Recruiting
Study of INCB123667 in Subjects With Advanced Solid Tumors
Condition
Solid Tumors
Enrollment
604 pts
Location
United States, France, Italy
Sponsor
Incyte Corporation
NCT05748730 N/A
Recruiting
Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention
Condition
Suicide and Depression
Enrollment
900 pts
Location
United States
Sponsor
University of Pittsburgh
NCT06152575 Phase 3
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in P...
Condition
Multiple Myeloma
Enrollment
492 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT05868265 Phase 2
Recruiting
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper U...
Condition
Urothelial Carcinoma
Enrollment
24 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06634719 N/A
Recruiting
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Condition
Heavy Menstrual Bleeding
Enrollment
7 pts
Location
United States
Sponsor
Rejoni Inc.
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05758545 N/A
Recruiting
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device...
Condition
Diabetic Foot Ulcer
Enrollment
450 pts
Location
United States
Sponsor
Piomic Medical
NCT04084730 Phase 2
Recruiting
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
Condition
Invasive Ductal Breast Carcinoma
Enrollment
280 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT02679144 Phase 2
Recruiting
Neuroblastoma Maintenance Therapy Trial
Condition
Neuroblastoma
Enrollment
441 pts
Location
United States, Canada
Sponsor
Giselle Sholler
NCT05358548 Phase 2
Recruiting
ATATcH Alternating Treatment Plans for Advanced Cancer
Condition
Head and Neck Cancer
Enrollment
150 pts
Location
United States
Sponsor
Rutgers, The State University
NCT03325855 N/A
Recruiting
Fecal Microbiota Transplant National Registry
Condition
Fecal Microbiota Transplantation
Enrollment
4,000 pts
Location
United States, Canada
Sponsor
American Gastroenterological A
NCT06697197 Phase 1, Phase 2
Recruiting
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advan...
Condition
Advanced Solid Tumors
Enrollment
413 pts
Location
United States, Belgium, Denmark
Sponsor
Bristol-Myers Squibb
NCT05985148 Phase 1
Recruiting
A Study of Stereotactic Radiosurgery (SRS) to Treat Pain in the Chest and/or Sto...
Condition
Thoracoabdominal Wall Pain
Enrollment
18 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06818643 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Adva...
Condition
Advanced Solid Tumors
Enrollment
270 pts
Location
United States, Chile, China
Sponsor
Merck Sharp & Dohme LLC
NCT02422550 N/A
Recruiting
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncol...
Condition
Radiation Therapy
Enrollment
837 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT03567889 Phase 3
Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/...
Condition
Melanoma Stage IIIB
Enrollment
186 pts
Location
United States, Spain, Switzerland
Sponsor
Philogen S.p.A.
NCT05591118 Phase 3
Recruiting
Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
Condition
Pulmonary Embolism
Enrollment
500 pts
Location
United States
Sponsor
NYU Langone Health
NCT05382338 Phase 3
Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hear...
Condition
Childhood Medulloblastoma
Enrollment
225 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT06751589 EARLY_Phase 1
Recruiting
A Study of a Weight Loss Intervention in People With Endometrial Cancer
Condition
Endometrial Cancer
Enrollment
36 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06276491 Phase 1
Recruiting
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Condition
Ovarian Cancer
Enrollment
282 pts
Location
United States
Sponsor
Xencor, Inc.
NCT05430490 N/A
Recruiting
Cannabis, HIV and Mental Processing Systems
Condition
HIV Infections
Enrollment
320 pts
Location
United States
Sponsor
Washington University School o